Join us on 26th Nov for the #REVIVE webinar on Innovations in point-of-care diagnostics for sepsis and bloodstream infections. #Sepsis #diagnostics

Do join us, tomorrow 26th Nov!!

Heartiest congratulations Ashok Deorari MD FAMS !

Sepsis is a leading cause of death in children under 5 & threatens achievement of SDG3. A new Lancet report shows sepsis deaths twice as high as previously thought. #GARDP is working with partners to develop new & improved treatments for neonatal sepsis: bit.ly/2FUefls

Antibiotic resistance has become a serious threat to human health around the world. We caught up with #AMR #diagnostic innovators and clinicians about their thoughts on the impact of #AMR on healthcare and the people facing these issues in India. youtube.com/watch?v=EfNUsr…

We are deeply saddened to learn the news that Dr. Peter Salama, epidemiologist and World Health Organization (WHO)'s Executive Director of the Division of Universal Health Coverage, has passed. Our thoughts are with his family and our friends and partners at WHO at this time.

This is a great loss to nation! Dr. M K Bhan was one of the greatest inspirations to us. Our prayers are with his family. May he rest in peace.

At the very onset of behavioural research for #AntibioticResistance stewardship we should perhaps curate stories of what hasn’t worked. Including the interventional methodology and failure nodes. This seems like a good step in that direction.

Health tools developed in wealthy countries can take 𝙙𝙚𝙘𝙖𝙙𝙚𝙨 to reach the people who need them most. By investing in home-grown innovation, we can accelerate and expand the reach of lifesaving breakthroughs 💉💊🔬. gates.ly/39WoS3U

"If you look at the Coronavirus #COVIDー19 conversation now, containment without providing care doesn’t work well. If you're not concerned with treatment, this is a colonial recipe for mistrust." -Paul Farmer Co-founder of Partners in Health, and Duke Trustee Duke Global Health Duke University

Just to re-up, diagnostic capacity is not a new issue. It's not just a COVID problem; it's a TB, antibiotic resistance, malaria, HIV, sepsis, cold problem forbes.com/sites/madhukar… @paimadhu

Where are our COVID19 positive patients? We need at scale screenings now! Anu Acharya Principal Scientific Adviser, Govt. of India

Lack of massive testing is where we will fail in ending this outbreak. What are we waiting for? #COVID #coronavirusindia

Ministry of Health ICMR Need your intervention to control prices for Rapid Kits. Rs. 200-300 kits are now costing Rs 1000 - pls look into this else the benefit of using Rapid Kits to quickly test millions of citizens at scale becomes economically impossible. StartupsVsCovid-19

#COVID19 interventions in resource-limited settings need to be affordable, available, and adapted to the health care systems and the populations they are serving. #COVID19crc The Lancet bit.ly/2UChxlj

DYK that even when new #antibiotics are approved, they rarely target priority #drugresistant bacteria and are only registered for use in a small number of countries? Find out how you can support our life-saving work right here: resist-resistance.gardp.org #ResistResistance

The Lancet Commission on #diagnostics: transforming access to diagnostics in #LMICs launched today! A great step in the right direction #DiagnosticCommission Diagnostics Commission thelancet.com/commissions/di…

A long supported innovation for #NeonatalHealth gets to the field & what better place to start than an underserved tribal community? CCAMP supported neonatal sepsis monitoring tech gets deployed in tribal majority Sargur, Karnataka in partnership with SELCO Foundation SpotSense

CCAMP CEO-Dir Dr Dr. Taslimarif Saiyed gives shout out to 3 deep science startups from CCAMP who are scaling succesfully in their "Method to Madness" Blackfrog Technologies Pvt. Ltd. Bioprime Agrisolutions Pvt Ltd @Spotsense Catch the conversation youtu.be/KRUw30aGrJg #IndiaAtVivaTech Viva Technology